d*****c
发帖数: 23 | 1 有人hold吗？公司的研发还在继续，Multikine的三期可能快开始了。
我转封CVM头的信。现在股价短期适中。
－－－－－－－－－
CEL-SCI Corporation Releases Letter to Shareholders
VIENNA, VA, July 7, 2009 – The following letter is being released by CEL-
SCI Corporation (NYSE AMEX: CVM) to its shareholders:
Dear Fellow Shareholders:
Recently we have been hearing a great deal about the pandemic caused by the
H1N1 swine flu. You may think to yourself, this is no big deal since it
does not seem that serious and, look what happened to bird flu - it
disappear... 阅读全帖 |
|
s**********9
发帖数: 846 | 2 This another subscriber only info: it is not as excited as RPC
It appears the long-awaited PHASE III trials for Cel-Sci's Multikine are
officially open, although we have not seen any official announcement from
the company.
Perhaps they are waiting until there are more people back in the market (
this week is traditionally slow) before they officially announce something
via an official press release. The company does have a number of days
grnted to them before they announce a material event.
Hav... 阅读全帖 |
|
s**********9
发帖数: 846 | 3 This another subscriber only info: it is not as excited as RPC
It appears the long-awaited PHASE III trials for Cel-Sci's Multikine are
officially open, although we have not seen any official announcement from
the company.
Perhaps they are waiting until there are more people back in the market (
this week is traditionally slow) before they officially announce something
via an official press release. The company does have a number of days
grnted to them before they announce a material event.
Hav... 阅读全帖 |
|
D**R
发帖数: 371 | 4 How about this one?
CVM
VIENNA, Va.--(BUSINESS WIRE)-- The following letter is being released by CEL
-SCI Corporation (NYSE AMEX: CVM) to its shareholders:
Dear Fellow Shareholders:
At the end of last year we were excited to report that we started our
pivotal Phase III trial for Multikine® in advanced primary head and neck
cancer. This study is designed to demonstrate that our novel approach to
the treatment of cancer is efficacious. If it is, as we believe the study
will show, we will be ab... 阅读全帖 |
|
D**R
发帖数: 371 | 5 How about this one?
CVM
VIENNA, Va.--(BUSINESS WIRE)-- The following letter is being released by CEL
-SCI Corporation (NYSE AMEX: CVM) to its shareholders:
Dear Fellow Shareholders:
At the end of last year we were excited to report that we started our
pivotal Phase III trial for Multikine® in advanced primary head and neck
cancer. This study is designed to demonstrate that our novel approach to
the treatment of cancer is efficacious. If it is, as we believe the study
will show, we will be ab... 阅读全帖 |
|
